Skip to main content

Curis Inc

CRIS
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001108205

No open-market purchases or sales by Curis Inc insiders were filed in the last 90 days; 37 institutions reported holding it in 13F filings for Q2 2026, worth $7.96M in total; Maverick Capital is the only superinvestor holding it.

Q1 2025 vs. Q4 2024

How the institutions holding Curis Inc changed between Q4 2024 and Q1 2025.

All holders in Q1 2025All holders in Q4 2024

13F holders of CRIS: Q4 2024 compared with Q1 2025
MeasureQ4 2024Of which not filed for Q1 2025Q1 2025Change
Holders40140+1
Shares3.21M14.67M+1.46M (+45.6%)
Value$9.81M$3$9.80M−$10.0K (−0.1%)

1 institution that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so the changes leave them out.

New holders (5)

Institutions that held Curis Inc at the end of Q1 2025 but not at the end of Q4 2024.

Institutions new to CRIS in Q1 2025
InstitutionSharesValue% of portfolio
XTX Topco Ltd12,941$27.2K0.00%
Steward Partners Investment Advisory, LLC1,597$3.35K0.00%
Jones Financial Companies LLLP120$2780.00%
Ronald Blue Trust, Inc.2$40.00%
Barclays PLC1$20.00%

Sold out (4)

Institutions that held Curis Inc at the end of Q4 2024 and filed for Q1 2025 without it.

Institutions that sold out of CRIS in Q1 2025
InstitutionShares, Q4 2024Value, Q4 2024
Millennium Management LLC25,557$78.2K
Engineers Gate Manager LP21,380$65.4K
Squarepoint Ops LLC11,564$35.4K
BNP Paribas Arbitrage, SA2$6

Not filed for Q1 2025 yet (1)

Institutions that held Curis Inc at the end of Q4 2024 and haven't filed a 13F for Q1 2025. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding CRIS in Q4 2024 that haven't filed for Q1 2025
InstitutionShares, Q4 2024Value, Q4 2024
WR Wealth Planners, LLC1$3